Replies to post #136578 on Biotech Values

[turtlepower]

Interesting point about dropouts. The original plan was to conduct analysis after 122 events and last december there had been more than that. The original plan was to also do an efficacy analysis every 25 events so if they did the analysis according to that plan after the 125th event the trial likely would have failed.